RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,298,900 | +66859.5% | 1,819,132 | 0.0% | 0.81% | -23.2% |
| Q2 2023 | $22,848 | -36.0% | 1,819,132 | -16.1% | 1.06% | -39.6% |
| Q1 2023 | $35,726 | -99.9% | 2,169,132 | 0.0% | 1.76% | +2.8% |
| Q4 2022 | $32,406,832 | -33.2% | 2,169,132 | 0.0% | 1.71% | -37.4% |
| Q3 2022 | $48,523,000 | +8.5% | 2,169,132 | -18.7% | 2.73% | -3.6% |
| Q2 2022 | $44,708,000 | -44.0% | 2,669,132 | 0.0% | 2.83% | -31.0% |
| Q1 2022 | $79,887,000 | -2.5% | 2,669,132 | 0.0% | 4.11% | +29.0% |
| Q4 2021 | $81,969,000 | +100.9% | 2,669,132 | +106.2% | 3.18% | +123.4% |
| Q3 2021 | $40,804,000 | -13.8% | 1,294,132 | 0.0% | 1.42% | -14.7% |
| Q2 2021 | $47,352,000 | +5.8% | 1,294,132 | 0.0% | 1.67% | +10.2% |
| Q1 2021 | $44,738,000 | -16.8% | 1,294,132 | 0.0% | 1.52% | -12.3% |
| Q4 2020 | $53,784,000 | +0.9% | 1,294,132 | +3.4% | 1.73% | -6.2% |
| Q3 2020 | $53,321,000 | – | 1,251,959 | – | 1.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |